Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
atorvastatin (lipitor) (2 trials)
allogeneic pancreatic islet cells (1 trial)
fenofibrate (fenoglide) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
insulin human (humulin) (1 trial)
insulin lispro (humalog) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Dyslipidemias (Phase 3)
Trials (4 total)
Trial APIs (6 total)